Skye Bioscience Inc (SKYE)

[botlow]

In my mind, it is just a matter of how cute I want to be trying to bottom tick it, because they have the five million in the bank that is all convertible at higher prices. They don't have to raise cash until probably early Q2 2016, so it is not like the stock is likely to go into any prolonged decline from these valuations. If they had not raised that cash, it easily could have. Did the stock get ahead of itself early in the year??? Yes. Did it overcorrect on the downside which is often the case when that happens? Again, IMO, YES. I bet we normalize closer to the midpoint of the range this year with some time, then the price will be data driven from there. Just one man's opinion.